These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461 [TBL] [Abstract][Full Text] [Related]
25. Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Uprety P; Mathew J; Weinstein MP; Kirn TJ Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115196. PubMed ID: 33220615 [No Abstract] [Full Text] [Related]
26. Comparison of three TaqMan real-time reverse transcription-PCR assays in detecting SARS-CoV-2. Xiao Y; Li Z; Wang X; Wang Y; Wang Y; Wang G; Ren L; Li J J Virol Methods; 2021 Feb; 288():114030. PubMed ID: 33275927 [TBL] [Abstract][Full Text] [Related]
27. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline. Kuchinski KS; Jassem AN; Prystajecky NA J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496 [TBL] [Abstract][Full Text] [Related]
28. Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis. Yoon SH; Yang S; Cho H; Eun S; Koo CM; Kim MK Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):503-517. PubMed ID: 33506942 [TBL] [Abstract][Full Text] [Related]
29. An Update on Advances in COVID-19 Laboratory Diagnosis and Testing Guidelines in India. Kumar KSR; Mufti SS; Sarathy V; Hazarika D; Naik R Front Public Health; 2021; 9():568603. PubMed ID: 33748054 [TBL] [Abstract][Full Text] [Related]
30. Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization. Lefferts JA; Allen SF; Steinmetz HB; Tsongalis GJ Clin Chem; 2021 Jan; 67(2):434-435. PubMed ID: 33315063 [No Abstract] [Full Text] [Related]
31. Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools. Liu S; Li Q; Chu X; Zeng M; Liu M; He X; Zou H; Zheng J; Corpe C; Zhang X; Xu J; Wang J Front Public Health; 2021; 9():672215. PubMed ID: 34164371 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic Modalities for the Detection of SARS-CoV-2: Principles, Advantages, and Pitfalls. Anand Bs S; Sujan J; N AK; M I Crit Rev Biomed Eng; 2020; 48(4):235-260. PubMed ID: 33463960 [TBL] [Abstract][Full Text] [Related]
33. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019. Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047 [TBL] [Abstract][Full Text] [Related]
34. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19. Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 testing and diagnosis: A comparison of current approaches. Wong RSY Malays J Pathol; 2021 Apr; 43(1):3-8. PubMed ID: 33903299 [TBL] [Abstract][Full Text] [Related]
36. Real-time RT-PCR for COVID-19 diagnosis: challenges and prospects. Sule WF; Oluwayelu DO Pan Afr Med J; 2020; 35(Suppl 2):121. PubMed ID: 33282076 [TBL] [Abstract][Full Text] [Related]
37. Strategic planning to augment the testing capacity for COVID-19 in India. Gupta N; Bhatnagar T; Rade K; Murhekar M; Gangakhedkar RR; Nagar A; Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):210-215. PubMed ID: 32362646 [TBL] [Abstract][Full Text] [Related]
38. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019. Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737 [TBL] [Abstract][Full Text] [Related]
39. New and developing diagnostic platforms for COVID-19: A systematic review. Chauhan N; Soni S; Gupta A; Jain U Expert Rev Mol Diagn; 2020 Sep; 20(9):971-983. PubMed ID: 32896179 [TBL] [Abstract][Full Text] [Related]
40. Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics. Erbak Yılmaz H; Iscan E; Oz O; Batur T; Erdoğan A; Kılıç S; Mutlu Z; Yılmaz M; Spring KJ Mol Biol Rep; 2022 Oct; 49(10):9725-9735. PubMed ID: 35441938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]